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NOTES AND COMMENTS 
New molecular techniques and the study of infection 
Recent advances in molecular techniques continue to 
offer exciting opportunities to identify new pathogens 
and unravel the complexity of microbial pathogenesis. 
Further application of this technology and the immi- 
nent release of data from the sequencing of entire 
microbial genomes heralds the dawn of a new era in the 
study of the infection process. 
Sequence-based identification of new pathogens, 
recently reviewed by Fredricks and Relman [l], utilizes 
nucleic acid amplification and in situ oligonucleotide 
hybridization to detect DNA of microorganisms 
thought to be associated with a disease process. Such 
techniques are useful in studying organisms which have 
not been characterized because they have proven, as 
yet, to be uncultivatable. One  method is to use the 
broadly conserved bacterial 16s rRNA sequences as 
targets for gene amplification. Once amplified, the 
products are sequenced and their phylogenetic relation- 
ship to 16s rRNA of other bacteria determined. 
The establishment of similarity with a known species 
allows the subsequent rational development of culture, 
serologic and other tests to aid characterization of 
the organism and confirm disease associations. This 
approach has led to the identification of the agents of 
bacillary angiomatosis (Bartonella kenselae) [2] and 
Whipple’s disease ( ZopherynTa wh@peli> [3] .  
Identification of new pathogens has also been 
achieved using representational difference analysis, 
which is a polymerase chain reaction (PCR)-based 
technique allowing the selective amplification of a 
unique sequence present in one of two otherwise 
identical populations of DNA [4]. This technique aims 
to identify microbial DNA present in diseased but 
not unaffected tissue, and has been used to detect 
herpesvirus-like sequences of DNA in Kaposi’s sarcoma 
tissue but not in normal skin of patients with the 
acquired immune deficiency syndrome (AIDS) [5] (see 
also this issue p. 159). 
One way to study microbial pathogenicity is to 
identify and characterize new virulence determinants 
by generating a pool ofisogenic mutants which are then 
screened for altered function. Insertional mutagenesis 
using mobile elements called transposons is a traditional 
technique that has been modified to allow specific 
virulence factors to be studied. Many important 
determinants are transported to the cell surface or 
secreted from the organism, and these may be identified 
using a transposon which encodes a marker that is 
only detectable once it is exported from the cell. An 
example is the TnphoA transposon which carries an 
alkaline phosphatase engineered to be active only after 
secretion from the organism [6]. After random muta- 
genesis by this transposon, screening for phosphatase- 
secreting mutants will identify insertion of the element 
into surface-associated or secreted products, and these 
clones can be readily identified and assessed further for 
attenuated virulence. 
Another modification is to use a transposon 
encoding a constitutive promoter which results in 
upregulation of the microbial gene immediately 
downstream of the point of insertion of the transposon. 
This allows mutants to be assessed for increased (rather 
than attenuated) function and has successfully been 
used to characterize the hi1 locus of Salmonella 
typhirnuriurn (important in cell entry by this organism 
in the mouse model of enteric fever) after randomly 
generated mutants were screened for increased invasion 
of cultured epithelial cells [7].  
Until recently the screening of generated mutants 
has been relatively laborious, as each mutant had to be 
tested individually and most procedures resulted in a 
negative phenotype (loss of function) which was often 
difficult to screen for in assays. Signature-tagged 
mutagenesis (STM) is a recently developed technique 
which allows attenuated clones to be readily identified 
in a large population of mutants [S]. It was developed 
in the Salmonella typhimurium mouse model and has 
already identified a new pathogenicity island in this 
organism. The procedure involves creating a large bank 
of randomly generated mutants by insertional muta- 
genesis using transposons which each carry a ‘tag’ of 
a short segment of DNA. Each tag has a unique 
identifying central sequence of 40 base pairs plus two 
conserved arms which allow amplification of the whole 
tag by common primers. The mutants are pooled, 
injected into the host animal and then recovered from 
the target organ (the spleen). Potentially important 
clones are identified by comparing the population of 
tags amplified from the pool injected into the animal 
and those recovered from the target organ. Those 
with attenuated virulence will not be recovered from 
the animal and will be absent from the latter popula- 
tion. Although originally designed for transposon 
mutagenesis, STM is potentially suitable for use in 
combination with other mutagenesis techniques. 
Directed mutagenesis techniques have the advan- 
tages that they are more focused and that screening is 
easier, as the products are of known or suspected 
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function. One PCR-based technique allows the 
identification of potential virulence factors and their 
mutagenesis in two stages [9].  Using primers designed 
fiom conserved sequences new members of important 
gene families can be amplified in a previously unstudied 
organism. The amplified product is then mutated in a 
second reaction which uses primers designed to misread 
the template, so introducing fiameshifts, stop codons 
and restriction enzyme sites. The latter allow the 
creation of defined deletions in the gene by digestion 
with the appropriate restriction enzyme. This combina- 
tion approach is rapid, reproducible and suitable for use 
in a wide variety of organisms, particularly those where 
traditional approaches do not work. 
Another method to identify gene products likely to 
be important in growth and colonization of a host is to 
examine patterns of gene expression under different 
growth conditions or in different models of infection. 
The specific induction of proteins under different 
growth conditions can be monitored by pulse labeling 
the bacteria with [35S]methionine, resolving the 
synthesized proteins by two-dimensional sodium 
dodecylsulfate-polyacrylamide gel electrophoresis (2D- 
SDS-PAGE) and comparing the gel profdes obtained. 
This has been successfully used in a number of 
organisms, including Salmonella typhimurium, where 
proteins important in the invasion of cells were 
identified by comparing gel patterns after labeling the 
organisms in the presence and absence of a fixed 
epithelial cell layer [lo]. 
Dfierential gene expression can also be studied at 
the mRNA level. One approach is to synthesize cDNA 
&om mRNA using a reverse transcription step and to 
compare levels of expression using subtractive cDNA 
hybridization. By comparing Mycobacterium avium 
cDNA expression in infected macrophages and in broth 
culture, one group has identified a gene that is highly 
induced in Mycobacterium avium during invasion of 
macrophages [ 1 11. 
Differential display is a PCR-based method that 
can directly detect differences in mRNA expression in 
eukaryotic cells or changes in response to different 
environmental conditions [12]. The mRNA popula- 
tion is amplified using arbitrary primers and the 
products are resolved on a sequencing gel to give a 
unique mRNA ‘fingerprint’. Comparison of the 
fingerprint profdes allows the identification of unique 
bands of dlfferentially displayed mRNAs which can be 
isolated, sequenced and studied further. This approach 
has been used to study the response of Salmonella 
typhimurium to oxidative stress induced by hydrogen 
peroxide [13]. Total RNA extracted from hydrogen 
peroxide-treated and -untreated cultures was amplified 
with six arbitrary primers and comparison of finger- 
prints identified a single differentially amplified product 
induced by oxidative stress. 
The study of infection is soon to be revolutionized 
by the development of technology which allows the 
sequencing of entire microbial genomes. Until recently 
this was a time-consuming process involving the 
creation of an ordered library of the genome, which 
was then sequenced sequentially. The more rapid 
approach adopted by the Institute for Genomic 
Research (TIGR) is to ‘shotgun’ sequence a random 
library of the genome using a bank of automated 
sequencers and to assemble the data using sophisticated 
computer collection and processing. This led to the 
publication of the genome sequence of Haemophilus 
inzuenrae last year [14]. Other centers are also involved 
in sequencing projects, and a number of important 
pathogens, including Mycobacterium tuberculosis and 
Helicobacterpylori, w d  be sequenced by the millennium. 
Assuming that such information is in the public 
domain, this will lead to a huge increase in our 
understandmg of the microbial pathogenesis of these 
organisms. Homology searches using existing databanks 
will readily identify recognized virulence determinants 
in new species. Comparison of entire genomes will 
identify factors unique to certain pathogens, as well as 
clarifying evolutionary relationshps between bacteria. 
Important genes may be identified by recognized 
regulatory sequences such as tetranucleotide repeats, 
and review of regulatory and transcription signals will 
allow a better understanding of the control of microbial 
gene expression. In theory it should be possible to 
identify all open reading frames of an organism and 
sequentially mutate its entire genome using directed 
mutagenesis approaches. Identification of novel and 
important virulence determinants in this way should 
lead to the discovery of suitable targets for the rational 
development of new chemotherapeutic agents and 
vaccine candidates. In the near future, application of 
new molecular techniques in combination with the 
availability of sequence data will allow the rapid 
dissection of entire microbial genomes, resulting in an 
unprecedented understanding of the infection process. 
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Susceptibility of coagulase-negative staphylococci to 
teicoplanin 
Clin Microbiol Infect 1996; 2: 000-000 
Coagulase-negative staphylococci (CNS) provide an 
increasing challenge in medicine, arising from their 
association with deep seated infections - often com- 
plicated by foreign bodies - and their resistance to 
commonly used antibiotics. The use of wide-spectrum 
agents in ‘decontamination’ for those at risk of systemic 
infections often selects CNS, for which intravascular 
access lines provide a convenient portal of entry. CNS 
infections demand therapy with a glycopeptide anti- 
biotic such as vancomycin or teicoplanin. However, 
both the terms ‘coagulase-negative staphylococci’, and 
‘glycopeptide’ cover agents with differing properties. 
As identification kits are expensive, the umbrella 
term CNS for organisms which are usually regarded as 
normal skin flora or contaminants in blood cultures has 
been much used. Nonetheless, identification of CNS 
to species level is important. Strains of Staphylococcus 
epidermidis, especially the slime-producing strains, 
are the commonest pathogenic CNS. Slime allows 
attachment to indwelling medical devices, is associated 
with more general resistance to antibiotics [I] and 
can antagonize glycopeptides [2]. Slime producers 
are usually S. epidermidis but occasionally Staphylococcus 
haemolyticus. Surveys show S. haemolyticus to be the 
second commonest pathogen - isolated particularly 
from patients with bacteremia [3,4], sometimes follow- 
ing nosocomial spread. 
Teicoplanin and vancomycin have similar structures 
but different antimicrobial and pharmacokinetic 
properties [5]. The lipophilic activity of teicoplanin 
may account for the difference. While both bind to the 
sticky d-Ma-d-Ma terminal chains of nascent peptido- 
glycan, vancomycin forms a dimer, while teicoplanin 
binds as a monomer [6]. In vitro tests for the suscepti- 
bility of CNS to teicoplanin have been problematic for 
two reasons: the effect of the medium used, and the 
poor diffusion of the large molecule in solid media. 
Felmingham et al. [7] found that the MIC varied 
with inoculum size and medium (e.g. 0.7 pg/mL on 
Isosensitest agar to 2.1 pg/mL. on Diagnostic Sensitivity 
Test [DST] medium). Others have reported poor 
correlation between tube-dilution MICs and disk 
susceptibility tests [8] even after increasing disk 
concentrations from 30 to 120 mg/L [9]. The NCCLS 
recommends a breakpoint of 232 mg/L for resistance 
[lo]. Most strains of CNS are susceptible according to 
this standard, but resistance has been encountered; 
Goldstein et al. [l 11 reported a rate of 1.7%. Resistance 
has been found in some strains of S. haemolyticus which 
are less susceptible to teicoplanin than vancomycin, 
although reference strains are susceptible [12]. Teico- 
planin resistance has been generated in S. haemolyticus 
laboratory strains [13], and reported as emerging in two 
strains of S. haemolyticus and one of S. epidermidis in 
neutropenic patients treated for bacteremia with the 
low dose of 200 mg teicoplanin daily [14]. Twenty- 
seven resistant strains of S. epidermidis were reported 
from France [ 151. 
In this context it is useful to review our own data 
from Papworth Hospital, Cambridge, UK. A study 
of wound infection following open-heart surgery 
[ 161 accompanied by perioperative prophylaxis with 
cloxacillin and gentamicin showed that cultures from 
inflamed but not frankly purulent wounds frequently 
grew CNS, which were regarded as contaminants. 
Archer and Armstrong [17] studied CNS on patients’ 
